National Institute of Allergy & Infectious Diseases

11-9-2020Cross-posted from NIAID NewsroomLong-Acting Regimen More Effective than Daily Oral Pill Among African WomenA pre-exposure prophylaxis (PrEP) regimen containing …

9-29-2020Cross-posted from NIAID Now BlogThe National Institutes of Health has awarded approximately $10 million to support implementation science research to advance th…

9-11-2020The COVID-19 Prevention Network (CoVPN) participates in conducting clinical trials to find safe and effective vaccines and monoclonal antibodies to protect peop…

8-26-2020Cross-posted from NIAID Now BlogInitial data from a large NIH-supported clinical trial offer a detailed look at the health status of people aging with HIV aroun…

8-20-2020Updates on progress in implementing the Ending the HIV Epidemic initiative are now available in a webinar recording on HIV.gov.

8-7-2020Video recording available of satellite session at AIDS 2020 with federal and community EHE leaders.

7-24-2020Cross-posted from NIAID NewsroomNIAID Celebrates Pivotal Step Toward Expanding HIV Prevention Choices for WomenToday the European Medicines Agency (EMA) announc…

7-24-2020Cross-posted from NIAID NewsroomMulticenter HOPE Act Study Expands Pool of Available KidneysKidney transplantation from deceased donors with HIV to people livin…

7-21-2020Cross-posted from NIAID NewsroomThe National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and IAVI, a nonprofit scie…

7-15-2020Last week HIV.gov covered new HIV research coming out of the 23rd International AIDS Conference (AIDS 2020: Virtual), sharing three video interviews about the l…